During the past decade, Oxford Childrens Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oxford Childrens Hospital" #1 sponsor was "Amgen" with 2 trials, followed by "Jaeb Center for Health Research" with 1 trials sponsored, "Ludwig-Maximilians - University of Munich" with 1 trials sponsored, "University Hospital Birmingham" with 1 trials sponsored and "University of Birmingham" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oxford Childrens Hospital" #1 collaborator was "Novartis" with 2 trials as a collaborator, "Andaluz Health Service" with 1 trials as a collaborator, "Bambino Gesù Hospital and Research Institute" with 1 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator and "Centre for Statistics in Medicine, Oxford" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Oxford Childrens Hospital" are "Migraine" (2 trials), "Autoimmune Diseases" (1 trials), "Carcinoma, Hepatocellular" (1 trials), "Crohn Disease" (1 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Oxford Childrens Hospital" in a lesser frequency.

Most popular intervention types in "Oxford Childrens Hospital" are "Drug" (5 trials), "Other" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Erenumab Dose 1" (2 trials), "Erenumab Dose 2" (2 trials), "Erenumab Dose 3" (2 trials) and "5Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oxford Childrens Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Oxford Childrens Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Oxford Childrens Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oxford Childrens Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".